FBC
SNY icon

Fairfield, Bush & Co’s Sanofi SNY Stock Holding History

Fairfield, Bush & Co’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$99 – 415
2023
Q4 		$99 Buy
+2
New +$98 ﹤0.01% 521
2023
Q3 		– Sell
-2
Closed -$108 – 433
2023
Q2 		$108 Buy
+2
New +$108 ﹤0.01% 549
2022
Q3 		– Sell
-502
Closed -$25K – 407
2022
Q2 		$25K Buy
+502
New +$26.6K 0.01% 241
2018
Q2 		– Sell
-2,200
Closed -$88K – 183
2018
Q1 		$88K Buy
+2,200
New +$91.5K 0.03% 164
2015
Q4 		– Sell
-6,118
Closed -$290K – 145
2015
Q3 		$290K Buy
6,118
+45
+0.7% +$2.29K 0.13% 105
2015
Q2 		$301K Hold
6,073
– – 0.09% 134
2015
Q1 		$300K Sell
6,073
-115
-2% -$5.5K 0.09% 136
2014
Q4 		$282K Hold
6,188
– – 0.08% 145
2014
Q3 		$349K Buy
6,188
+85
+1% +$4.57K 0.1% 130
2014
Q2 		$324K Buy
+6,103
New +$324K 0.1% 132
2013
Q4 		– Sell
-6,103
Closed -$308K – 226
2013
Q3 		$308K Hold
6,103
– – 0.09% 123
2013
Q2 		$314K Buy
+6,103
New +$325K 0.16% 106

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Fairfield, Bush & Co's SNY Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Sanofi (SNY) in Q1 2024, closing a stake of 2 shares — an estimated $99 sold.

Fairfield, Bush & Co first reported a position in SNY in Q2 2013 and held it in 12 quarters. The position peaked at $349K in Q3 2014. 713 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining Sanofi position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 2 Sanofi shares in Q1 2024, an estimated $99.
  • Fairfield, Bush & Co first reported a position in Sanofi in Q2 2013 and held it in 12 quarters.
  • Fairfield, Bush & Co's Sanofi position peaked at $349K in Q3 2014.
  • 713 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.